Atterx Biotherapeutics

Biotherapeutical development

Based in WI

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $165K in lobbying spend across 12 quarterly filings, Atterx Biotherapeutics is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2023 to 2025.

$165K
Total Spend
3
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$45K
2024$60K
2025$60K

Issues Lobbied

Budget/AppropriationsMED

Lobbying Firms

Capstone National Partners

Lobbyists

Christopher CzarneckiWilliam Stone

Government Agencies Targeted

These are the government entities that Atterx Biotherapeutics disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, MED

FY 24 Appropriations

research funding

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Children's Hospital and Health System, INC.
$3.5M total spend
Minnesota Society of Anesthesiologists
$110K total spend
Board of Regents of University of Wisconsin System
$2.3M total spend
Marinette Marine Corporation
$2.2M total spend
Fincantieri Marine Group LLC
$1.6M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.